Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT06317701

Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation

Led by University of Chicago · Updated on 2026-01-28

30

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to determine if the treatment of Obstructive sleep apnea (OSA) by hypoglossal nerve stimulation (HGNS) will alter glucose metabolism. The study team will also determine if the treatment of Obstructive sleep apnea (OSA) by (hypoglossal nerve stimulation) HGNS will alter predictors of cardiovascular outcomes.

CONDITIONS

Official Title

Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Overweight or obese males and females with BMI 25 kg/m2 to 40 kg/m2
  • Age 18 years and older
  • Diagnosed with obstructive sleep apnea by Apnea-Hypopnea Index >15 events/hr using 4% oxygen desaturation criteria and <25% central events/hr on prior sleep testing
  • Not able to use positive airway pressure >4 hours for 5 nights/week or unwilling to use positive airway pressure
Not Eligible

You will not qualify if you...

  • Insulin-dependent Diabetes
  • Inability to undergo in-lab polysomnography or home sleep testing
  • Central Nervous System disease with cognitive impairment or muscle weakness (e.g., stroke)
  • Currently pregnant, trying to get pregnant, or nursing
  • Age under 18 years
  • Regular and adherent CPAP use per clinical guidelines
  • Current night shift or rotating shift work
  • Diagnosis of another sleep disorder (e.g., periodic limb movement disorder)
  • Current systemic steroid use
  • Predominantly central sleep apnea or requiring advanced positive airway pressure modalities
  • Protected patient under legal guardianship or hospitalized without consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

Loading map...

Research Team

P

Phillip LoSavio, MD, MS

CONTACT

C

Carlisa Dixon

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here